Summary of a consensus conference on heart-liver transplantation

Kobashigawa, Jon; VanWagner, Lisa B.; Hall, Shelley; Emamaullee, Juliet; Entwistle, John W.; Ganger, Daniel; Gebel, Howard; Jeevanandam, Valluvan; Kaldas, Fady; Kilic, Ahmet; Kittleson, Michelle; Kushwaha, Sudhir; Kwong, Allison; Lui, George K.; Motayagheni, Negar; Patel, Jignesh; Patel, Nikhil; Pereira, Naveen; Potter, Lisa; Sani, Maryam; Schiano, Thomas D.; Shingina, Alexandra; Kobashigawa, Jon; VanWagner, Lisa B.; Hall, Shelley; Ardehali, Abbas; Baran, David; Bhimaraj, Arvind; Bonham, Clark Andrew; Breda, Joao Roberto; Chen, Sharon; Czer, Lawrence; Alessandro, David D'; Daugherty, Tami; De Marco, Teresa; Emamaullee, Juliet; Emerson, Dominic; Entwistle, John W.; Esmailian, Fardad; Estep, Jerry; Gaber, Osama; Ganger, Daniel; Gebel, Howard; Ebel, Noelle Hanako; Harmath, Carla; Heimbach, Julie; Izzy, Manhal; Jackson, Annette; Jeevanandam, Val; Kahn, Jeffrey; Kaldas, Fady; Kamath, Patrick; Kilic, Ahmet; Kittleson, Michelle; Kuo, Alex; Kushwaha, Sudhir; Kwong, Allison; Lewis, Matthew; Loebe, Matthias; Lui, George; Madsen, Joren; McLean, Rhondalyn; Menachem, Jonathan; Mobley, Constance; Mufti, Arji; Patel, Jignesh; Pereira, Naveen; Pinney, Sean; Potter, Lisa; Sack, Jordan; Sahota, Amandeep; Schiano, Thomas D.; Schlendorf, Kelly; Shingina, Alexandra; Takeda, Koji; Taner, Timucin; Te, Helen; Teuteberg, Jeffrey; Tompkins, Rose; Verna, Betsy; Wall, Anji

doi:10.1016/j.ajt.2023.12.002

American Journal of Transplantation

2024

DOI: 10.1016/j.ajt.2023.12.002

|View full text |Cite

Summary of a consensus conference on heart-liver transplantation

Jon Kobashigawa,

Lisa B. VanWagner,

Shelley Hall

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Fontan-Associated Liver Disease and the Double Organ Transplant: Addressing the Heart of the Argument

Ravanbakhsh,

Emamaullee

2024

Curr Treat Options Peds

View full text Add to dashboard Cite

Fontan-Associated Liver Disease and the Double Organ Transplant: Addressing the Heart of the Argument

Ravanbakhsh,

Emamaullee

2024

Curr Treat Options Peds

View full text Add to dashboard Cite

The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change

Schiano,

Ganger

2024

Liver Transplantation

View full text Add to dashboard Cite

show abstract

Combined Heart-Liver Transplant vs. Heart Transplant Alone: A Single Center Experience

Mazumder,

Ford,

Sims

et al. 2024

Transplantology

View full text Add to dashboard Cite

Combined heart-liver transplantation (CHLT) is a viable option for concurrent heart and liver failure, yet its indications are unclear. This preliminary study aimed to describe pre-transplant characteristics and outcomes of patients with liver fibrosis undergoing HT and CHLT, while exploring decompensated liver dysfunction following HT. A total of 52 patients (HT = 42; CHLT = 10) were included. In HT patients, F1 fibrosis was more common (52%), with 43% exhibiting F3 or F4 fibrosis. F4 fibrosis was predominant in the CHLT patients (80%). Post-hepatic portal hypertension was present in 62% of HT and 90% of CHLT patients. None progressed to liver decompensation (i.e., new ascites, variceal bleed, jaundice, hepatic hydrothorax, or hepatic encephalopathy) after HT. Over a median follow-up period of 3.7 [IQR 1.2–9.1] years, the two groups did not differ statistically in survival (p = 0.60). Altogether, HT and CHLT may have similar survival outcomes, and HT patients may not progress to decompensation postoperatively despite advanced fibrosis. Decompensated cirrhosis could serve as a factor for identifying CHLT candidates, but it is crucial to differentiate it from post-hepatic portal hypertension, which does not necessitate liver transplant. Further research is needed to determine selection criteria for CHLT, ensuring efficient utility of organs.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Summary of a consensus conference on heart-liver transplantation

Cited by 3 publications

References 26 publications

Fontan-Associated Liver Disease and the Double Organ Transplant: Addressing the Heart of the Argument

Fontan-Associated Liver Disease and the Double Organ Transplant: Addressing the Heart of the Argument

The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change

Combined Heart-Liver Transplant vs. Heart Transplant Alone: A Single Center Experience

Contact Info

Product

Resources

About